Natural Health Science Foundation Assessment Further Verifies Tilray Medical’s High-Quality Standard and its CBD100 Product for Clinical Trial Use
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live…
Clever, personable, and wonderfully unconventional, yet reader-friendly, Tilray Medical has recently received verification from the prestigious Natural Health Science Foundation for their high-quality standard and their CBD100 product for clinical trial use.
This verification further solidifies Tilray’s reputation as a trusted and reliable provider of medical cannabis products. The Natural Health Science Foundation is known for its rigorous assessment process, so receiving their stamp of approval is a significant achievement for Tilray.
The CBD100 product, in particular, has been garnering attention for its potential therapeutic benefits. With the validation from the Natural Health Science Foundation, researchers and healthcare professionals can have confidence in the quality and efficacy of this product for use in clinical trials.
Tilray’s commitment to excellence and innovation in the medical cannabis industry is evident in this latest verification. By meeting the rigorous standards set by the Natural Health Science Foundation, Tilray is demonstrating its dedication to providing patients with safe and effective treatment options.
How this will affect me:
As a potential patient looking for alternative treatment options, the verification of Tilray Medical’s CBD100 product by the Natural Health Science Foundation gives me assurance that I am using a high-quality and trustworthy product. This validation allows me to explore medical cannabis as a potential treatment with confidence in its safety and efficacy.
How this will affect the world:
The verification of Tilray Medical’s CBD100 product by the Natural Health Science Foundation has far-reaching implications for the medical cannabis industry. By setting a high standard for quality and efficacy, Tilray is raising the bar for other companies in the field. This validation not only benefits patients by ensuring they have access to safe and effective treatment options but also contributes to the overall legitimacy and credibility of medical cannabis as a viable form of therapy.
Conclusion:
In conclusion, Tilray Medical’s verification by the Natural Health Science Foundation is a significant milestone that highlights the company’s commitment to excellence and innovation in the medical cannabis industry. This validation not only benefits patients by providing them with a high-quality treatment option but also elevates the industry as a whole. With the CBD100 product now validated for clinical trial use, Tilray is poised to make a meaningful impact on the future of medical cannabis research and therapy.
